Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.

Literature DB >> 32586918

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.

Arielle Mendel¹, Sasha Bernatsky^2,3, Anca Askanase⁴, Sang-Cheol Bae⁵, Ann Elaine Clarke⁶, Nathalie Costedoat-Chalumeau⁷, Dafna D Gladman⁸, Caroline Gordon^9,10, John Hanly¹¹, Søren Jacobsen¹², Ken Kalunian¹³, Anselm Mak¹⁴, Marta Mosca¹⁵, Bernardo A Pons-Estel¹⁶, Guillermo Ruiz-Irastorza¹⁷, Murray Urowitz⁸, Évelyne Vinet^2,3.

Abstract

Entities: Chemical Disease Species

Keywords: epidemiology; hydroxychloroquine; lupus erythematosus; systemic

Mesh：

Substances：

Year: 2020 PMID： 32586918 DOI： 10.1136/annrheumdis-2020-218164

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

1. [Translated article] Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19.

Authors: D Morgado-Carrasco; J Ibaceta-Ayala; J Piquero-Casals
Journal: Actas Dermosifiliogr Date: 2022-02

Review 2. The Lancet Commission on lessons for the future from the COVID-19 pandemic.

Authors: Jeffrey D Sachs; Salim S Abdool Karim; Lara Aknin; Joseph Allen; Kirsten Brosbøl; Francesca Colombo; Gabriela Cuevas Barron; María Fernanda Espinosa; Vitor Gaspar; Alejandro Gaviria; Andy Haines; Peter J Hotez; Phoebe Koundouri; Felipe Larraín Bascuñán; Jong-Koo Lee; Muhammad Ali Pate; Gabriela Ramos; K Srinath Reddy; Ismail Serageldin; John Thwaites; Vaira Vike-Freiberga; Chen Wang; Miriam Khamadi Were; Lan Xue; Chandrika Bahadur; Maria Elena Bottazzi; Chris Bullen; George Laryea-Adjei; Yanis Ben Amor; Ozge Karadag; Guillaume Lafortune; Emma Torres; Lauren Barredo; Juliana G E Bartels; Neena Joshi; Margaret Hellard; Uyen Kim Huynh; Shweta Khandelwal; Jeffrey V Lazarus; Susan Michie
Journal: Lancet Date: 2022-09-14 Impact factor: 202.731

Review 3. The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data.

Authors: Wei Tang; Leila Khalili; Jon Giles; Yevgeniya Gartshteyn; Teja Kapoor; Cathy Guo; Tommy Chen; Deborah Theodore; Anca Askanase
Journal: Rheumatol Ther Date: 2021-05-24

Review 4. SARS-CoV-2 and Systemic Lupus Erythematosus.

Authors: Aikaterini Thanou; Amr H Sawalha
Journal: Curr Rheumatol Rep Date: 2021-01-28 Impact factor: 4.592

5. The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study.

Authors: Melanie Sloan; Caroline Gordon; Rupert Harwood; Elliott Lever; Chris Wincup; Michael Bosley; James Brimicombe; Mark Pilling; Stephen Sutton; Lynn Holloway; David D'Cruz
Journal: Rheumatol Adv Pract Date: 2020-12-14

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.

1. [Translated article] Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19.

Review 2. The Lancet Commission on lessons for the future from the COVID-19 pandemic.

Review 3. The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data.

Review 4. SARS-CoV-2 and Systemic Lupus Erythematosus.

5. The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal study.

Review 6. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease.

7. Lupus in the 21st century.

8. Challenges of Egyptian patients with systemic lupus erythematosus during the COVID-19 pandemic.

Review 9. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing.

10. [Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].